IW
GILD icon

Imprint Wealth’s Gilead Sciences GILD Stock Holding History

Imprint Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.27K Hold
45
– – 0.03% 152
2025
Q4 		$5.52K Sell
45
-97
-68% -$11.8K 0.03% 185
2025
Q3 		$15.8K Buy
+142
New +$16.1K 0.05% 148
2024
Q1 		$266K Buy
3,648
+301
+9% +$23.1K 0.06% 246
2023
Q4 		$271K Buy
3,347
+576
+21% +$44.8K 0.22% 128
2023
Q3 		$208K Buy
+2,771
New +$213K 0.18% 141

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Imprint Wealth's GILD Position: Q1 2026 in Review

Imprint Wealth held its Gilead Sciences (GILD) position steady in Q1 2026 at 45 shares worth $6.27K. The position accounts for 0.03% of the portfolio, ranked #152.

Imprint Wealth first reported a position in GILD in Q3 2023 and has held it in 6 quarters since. The position peaked at $271K in Q4 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Imprint Wealth held 45 shares of Gilead Sciences worth $6.27K as of Q1 2026.
  • Imprint Wealth left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.03% of Imprint Wealth's portfolio in Q1 2026, its #152 holding.
  • Imprint Wealth first reported a position in Gilead Sciences in Q3 2023 and has held it in 6 quarters since.
  • Imprint Wealth's Gilead Sciences position peaked at $271K in Q4 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Imprint Wealth's 13F filing for Q1 2026, filed 15 May 2026.